Cargando…
Prosaposin Reduces α-Synuclein in Cells and Saposin C Dislodges it from Glucosylceramide-enriched Lipid Membranes
Parkinson’s disease (PD) is the second most common progressive neurodegenerative disorder affecting over 1% of the 65 + age population. Saposin C, a lysosomal protein required for the normal activity of glucocerebrosidase (GCase), may serve as a disease modifier in PD. Saposin C is cleaved from its...
Autores principales: | Kojima, Rika, Zurbruegg, Mark, Li, Tianyi, Paslawski, Wojciech, Zhang, Xiaoqun, Svenningsson, Per |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726671/ https://www.ncbi.nlm.nih.gov/pubmed/36152140 http://dx.doi.org/10.1007/s12031-022-02066-y |
Ejemplares similares
-
Regional expression of prosaposin in the wild-type and saposin D-deficient mouse brain detected by an anti-mouse prosaposin-specific antibody
por: Yoneshige, Azusa, et al.
Publicado: (2009) -
Decreased Prosaposin and Progranulin in the Cingulate Cortex Are Associated with Schizophrenia Pathophysiology
por: He, Yachao, et al.
Publicado: (2022) -
Prosaposin maintains lipid homeostasis in dopamine neurons and counteracts experimental parkinsonism in rodents
por: He, Yachao, et al.
Publicado: (2023) -
α-Synuclein induced cholesterol lowering increases tonic and reduces depolarization-evoked synaptic vesicle recycling and glutamate release
por: Lazarevic, Vesna, et al.
Publicado: (2022) -
α-synuclein−lipoprotein interactions and elevated ApoE level in cerebrospinal fluid from Parkinson's disease patients
por: Paslawski, Wojciech, et al.
Publicado: (2019)